Cape Investment Advisory’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$75.2K Buy
+150
New +$72K 0.02% 394
2026
Q1
Sell
-70
Closed -$40.6K 1112
2025
Q4
$40.6K Buy
70
+4
+6% +$2.26K 0.01% 466
2025
Q3
$32K Buy
66
+6
+10% +$2.79K 0.03% 270
2025
Q2
$24.3K Buy
60
+7
+13% +$2.93K 0.01% 472
2025
Q1
$26.4K Hold
53
0.01% 430
2024
Q4
$27.6K Sell
53
-14
-21% -$7.7K 0.01% 427
2024
Q3
$41.4K Buy
67
+3
+5% +$1.78K 0.02% 344
2024
Q2
$35.4K Buy
64
+14
+28% +$8.02K 0.02% 346
2024
Q1
$29.1K Sell
50
-26
-34% -$14.6K 0.01% 391
2023
Q4
$40.3K Buy
76
+26
+52% +$12.6K 0.02% 386
2023
Q3
$25.3K Hold
50
0.01% 406
2023
Q2
$26.1K Hold
50
0.01% 398
2023
Q1
$28.8K Buy
+50
New +$28.2K 0.02% 363

Other funds holding TMO

Cape Investment Advisory's TMO Position: Q2 2026 in Review

Cape Investment Advisory opened a new position in Thermo Fisher Scientific (TMO) in Q2 2026: 150 shares worth $75.2K. The stake represents 0.02% of the portfolio and ranks #394 among its holdings. This is a return to the name: Cape Investment Advisory previously reported a position in TMO as recently as Q4 2025.

Cape Investment Advisory first reported a position in TMO in Q1 2023 and has held it in 13 quarters since. 704 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Cape Investment Advisory held 150 shares of Thermo Fisher Scientific worth $75.2K as of Q2 2026.
  • Thermo Fisher Scientific was a new Cape Investment Advisory position in Q2 2026.
  • Thermo Fisher Scientific made up 0.02% of Cape Investment Advisory's portfolio in Q2 2026, its #394 holding.
  • Cape Investment Advisory first reported a position in Thermo Fisher Scientific in Q1 2023 and has held it in 13 quarters since.
  • 704 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Cape Investment Advisory's 13F filing for Q2 2026, filed 23 Jul 2026.